Allogene Therapeutics
- Biological Products, Except Diagnostic Substances
- South San Francisco, California
Compensation history
Top executives at Allogene Therapeutics received an average of $5M per person in annual compensation from 2018 to 2021.
Average pay of disclosed executives at Allogene Therapeutics
By year
Executives
We found six executives who work or worked at Allogene Therapeutics.
David Chang
Allogene Therapeutics
Chief Executive Officer
Eric Schmidt
Allogene Therapeutics
Chief Financial Officer
Rafael Amado
Allogene Therapeutics
Chief Medical Officer
Alison Moore
Allogene Therapeutics
Chief Technical Officer
Veer Bhavnagri
Allogene Therapeutics
General Counsel
Joshua Kazam
Allogene Therapeutics
Former President
News
Allogene Therapeutics CEO David Chang's 2021 pay jumps 30% to $10M
April 26, 2022
Allogene Therapeutics CEO David Chang's 2020 pay falls 30% to $7.8M
April 22, 2021
Allogene Therapeutics CEO David Chang's 2019 pay slips 13% to $11M
April 23, 2020
Allogene Therapeutics CEO David Chang receives $13M in 2018
April 24, 2019
About Allogene Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address210 East Grand Avenue, South San Francisco, California 94080
- Phone(650) 457-2700
- Fiscal year endDecember 31
Source: SEC filings on April 26, 2022, April 22, 2021, April 23, 2020, and April 24, 2019.